Literature DB >> 32213019

Pouchitis: Treatment dilemmas at different stages of the disease.

Manuel Barreiro-de Acosta1, Iria Bastón-Rey1, Cristina Calviño-Suárez1, J Enrique Domínguez-Muñoz1.   

Abstract

Pouchitis is a frequent complication in ulcerative colitis patients after proctocolectomy with ileal pouch-anal anastomosis. It is an unspecific inflammation of the pouch with unknown aetiology. First-line treatment for acute and chronic pouchitis is antibiotics. Some cases of severe chronic refractory pouchitis may benefit from biological treatment. Anti-tumour necrosis factor should be recommended as the first option, leaving the new biologicals for multirefractory patients. Permanent ileostomy may be an option in severe cases, after failure of medical treatment. Prophylaxis therapy with a probiotic mixture is recommended after the first episode of pouchitis, whereas it is not clear whether probiotics are useful for all patients after surgery. Here, we present a case report and review the treatment options in different forms of pouchitis.

Entities:  

Keywords:  Ulcerative colitis; anti-TNF; antibiotics; pouchitis; probiotics

Mesh:

Substances:

Year:  2020        PMID: 32213019      PMCID: PMC7184652          DOI: 10.1177/2050640619900571

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  35 in total

1.  Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy.

Authors:  Revital Kariv; Feza H Remzi; Lei Lian; Ana E Bennett; Ravi P Kiran; Yehuda Kariv; Victor W Fazio; Ian C Lavery; Bo Shen
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram.

Authors:  Bo Shen; Changhong Yu; Lei Lian; Feza H Remzi; Ravi P Kiran; Victor W Fazio; Michael W Kattan
Journal:  J Crohns Colitis       Date:  2011-09-09       Impact factor: 9.071

Review 3.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

4.  Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.

Authors:  Manuel Barreiro-de Acosta; Orlando García-Bosch; Jordi Gordillo; Miriam Mañosa; Luis Menchén; Raquel Souto; Ignacio Marin-Jimenez
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-07       Impact factor: 2.566

5.  Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.

Authors:  Manuel Barreiro-de Acosta; Ana Gutierrez; Iago Rodríguez-Lago; Eloy Espín; Isabel Ferrer Bradley; Ignacio Marín-Jimenez; Belén Beltrán; María Chaparro; Javier P Gisbert; Pilar Nos
Journal:  Gastroenterol Hepatol       Date:  2019-10-09       Impact factor: 2.102

6.  Disease course and management strategy of pouch neoplasia in patients with underlying inflammatory bowel diseases.

Authors:  Xian-Rui Wu; Feza H Remzi; Xiu-Li Liu; Lei Lian; Luca Stocchi; Jean Ashburn; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

7.  Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.

Authors:  B Shen; A Brzezinski; V W Fazio; F H Remzi; J-P Achkar; A E Bennett; K Sherman; B A Lashner
Journal:  Aliment Pharmacol Ther       Date:  2005-10-15       Impact factor: 8.171

Review 8.  Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis.

Authors:  D S Pardi; B Shen
Journal:  Endoscopy       Date:  2008-05-08       Impact factor: 10.093

9.  Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.

Authors:  Jacob E Ollech; David T Rubin; Laura Glick; Roni Weisshof; Katia El Jurdi; Amanda Israel; Noa Krugliak Cleveland; Neil Hyman; Atsushi Sakuraba; Joel Pekow; Russell D Cohen; Sushila R Dalal
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

10.  Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Authors:  Levente Parragi; N Fournier; Jonas Zeitz; Michael Scharl; Thomas Greuter; Philipp Schreiner; Benjamin Misselwitz; Ekaterina Safroneeva; A M Schoepfer; Stephan R Vavricka; Gerhard Rogler; Luc Biedermann
Journal:  J Crohns Colitis       Date:  2018-06-28       Impact factor: 9.071

View more
  2 in total

1.  The natural history of extraintestinal manifestations after surgery in inflammatory bowel disease: Never give up!

Authors:  Iago Rodríguez-Lago; Manuel Barreiro-de Acosta
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 6.866

Review 2.  Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy.

Authors:  Roberto Gabbiadini; Arianna Dal Buono; Carmen Correale; Antonino Spinelli; Alessandro Repici; Alessandro Armuzzi; Giulia Roda
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.